Financhill
Back

Rigel Pharmaceuticals Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
54

RIGL
Rigel Pharmaceuticals

Last Price:
14.80
Seasonality Move:
14.12%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Rigel Pharmaceuticals Price Quote

$14.80
+0.30 (+2.07%)
(Updated: November 6, 2024 at 10:30 AM ET)

Rigel Pharmaceuticals Key Stats

Buy
54
Rigel Pharmaceuticals (RIGL) is a Buy

Day range:
$13.91 - $14.57
52-week range:
$7.48 - $17.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.95
P/B ratio:
0%

Volume:
116.7K
Avg. volume:
168.1K
1-year change:
64.57%
Market cap:
$255.1M
Revenue:
$116.9M
EPS:
$-0.76

How Much Does Rigel Pharmaceuticals Make?

Is Rigel Pharmaceuticals Growing As A Company?

  • What Is Rigel Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.37%
  • What Is Rigel Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Rigel Pharmaceuticals Stock Price Performance

What Is Rigel Pharmaceuticals 52-Week High & Low?

Rigel Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rigel Pharmaceuticals?

Is Rigel Pharmaceuticals Cash Flow Positive?

  • What Is RIGL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$12.3M
  • What Is Rigel Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$3.6M
  • What Is Rigel Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $3.2M

Rigel Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RIGL return on invested capital is -48.07%
  • What Is Rigel Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -11.77%
  • What Is RIGL Return On Equity?
    ROE is a measure of profitability and is 0%

Rigel Pharmaceuticals Earnings Date & Stock Price

Rigel Pharmaceuticals Competitors

Rigel Pharmaceuticals Dividend Yield

Rigel Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 66.22%
Revenue: 37.03% 9.31%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 26.75
Upside from Last Price: 84.48%

Major Shareholders

  • How many RIGL shares are owned by institutional investors?
    32.2M RIGL shares are owned by institutional investors
  • How many RIGL shares are owned by insiders?
    4.3M RIGL shares are owned by insiders